Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Pulmonx Analyst Ratings
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $16
CCORF Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Piper Sandler Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $10
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $17
Analysts Are Bullish on Top Healthcare Stocks: Pulmonx (LUNG), Omnicell (OMCL)
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Wells Fargo Reaffirms Their Hold Rating on Pulmonx (LUNG)
Wells Fargo Maintains Pulmonx(LUNG.US) With Hold Rating, Maintains Target Price $10
Aeriseal's Market Potential and Safety Profile: Justifying a Hold Rating for Pulmonx
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Pulmonx (LUNG) Gets a Buy From Lake Street
CCORF Maintains Pulmonx(LUNG.US) With Buy Rating, Raises Target Price to $16
Buy Rating Affirmed for Pulmonx: Strong Growth and Promising Clinical Advancements
Pulmonx Price Target Cut to $10.00/Share From $14.00 by Wells Fargo